Literature DB >> 15239958

PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development.

Aaron D Gitler1, Min Min Lu, Jonathan A Epstein.   

Abstract

The identification of new signaling pathways critical for cardiac morphogenesis will contribute to our understanding of congenital heart disease (CHD), which remains a leading cause of mortality in newborn children worldwide. Signals mediated by semaphorin ligands and plexin receptors contribute to the intricate patterning of axons in the central nervous system. Here, we describe a related signaling pathway involving secreted class 3 semaphorins, neuropilins, and a plexin receptor, PlexinD1, expressed by endothelial cells. Interruption of this pathway in mice results in CHD and vascular patterning defects. The type of CHD caused by inactivation of PlexinD1 has previously been attributed to abnormalities of neural crest. Here, we show that this form of CHD can be caused by cell-autonomous endothelial defects. Thus, molecular programs that mediate axon guidance in the central nervous system also function in endothelial cells to orchestrate critical aspects of cardiac morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15239958     DOI: 10.1016/j.devcel.2004.06.002

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  139 in total

1.  Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels.

Authors:  Stryder M Meadows; Peter J Fletcher; Carlos Moran; Ke Xu; Gera Neufeld; Sophie Chauvet; Fanny Mann; Paul A Krieg; Ondine Cleaver
Journal:  Circ Res       Date:  2011-11-10       Impact factor: 17.367

Review 2.  Axon guidance molecules in vascular patterning.

Authors:  Ralf H Adams; Anne Eichmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-31       Impact factor: 10.005

3.  Targeted genome-wide investigation identifies novel SNPs associated with diabetic nephropathy.

Authors:  Amy Jayne McKnight; Diane Currie; Chris C Patterson; Alexander P Maxwell; Damian G Fogarty
Journal:  Hugo J       Date:  2010-02-24

4.  PlexinD1 is required for proper patterning of the periocular vascular network and for the establishment of corneal avascularity during avian ocular development.

Authors:  Sam C Kwiatkowski; Ana F Ojeda; Peter Y Lwigale
Journal:  Dev Biol       Date:  2016-01-16       Impact factor: 3.582

5.  Single-cell analysis of endothelial morphogenesis in vivo.

Authors:  Jianxin A Yu; Daniel Castranova; Van N Pham; Brant M Weinstein
Journal:  Development       Date:  2015-08-07       Impact factor: 6.868

6.  Inactivation of the Sema5a gene results in embryonic lethality and defective remodeling of the cranial vascular system.

Authors:  Roberto Fiore; Belquis Rahim; Vincent M Christoffels; Antoon F M Moorman; Andreas W Püschel
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  GIPC proteins negatively modulate Plexind1 signaling during vascular development.

Authors:  Jorge Carretero-Ortega; Zinal Chhangawala; Shane Hunt; Carlos Narvaez; Javier Menéndez-González; Carl M Gay; Tomasz Zygmunt; Xiaochun Li; Jesús Torres-Vázquez
Journal:  Elife       Date:  2019-05-03       Impact factor: 8.140

8.  Autocrine VEGF signaling is required for vascular homeostasis.

Authors:  Sunyoung Lee; Tom T Chen; Chad L Barber; Maria C Jordan; Jared Murdock; Sharina Desai; Napoleone Ferrara; Andras Nagy; Kenneth P Roos; M Luisa Iruela-Arispe
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

9.  Endocardial Hippo signaling regulates myocardial growth and cardiogenesis.

Authors:  Stanley Artap; Lauren J Manderfield; Cheryl L Smith; Andrey Poleshko; Haig Aghajanian; Kelvin See; Li Li; Rajan Jain; Jonathan A Epstein
Journal:  Dev Biol       Date:  2018-05-01       Impact factor: 3.582

10.  Tie2Cre-mediated inactivation of plexinD1 results in congenital heart, vascular and skeletal defects.

Authors:  Ying Zhang; Manvendra K Singh; Karl R Degenhardt; Min Min Lu; Jean Bennett; Yutaka Yoshida; Jonathan A Epstein
Journal:  Dev Biol       Date:  2008-10-17       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.